Trevor Mundel - Articles and news items

GlaxoSmithKline logo

New partnership between GSK and the Bill & Melinda Gates Foundation to accelerate research into vaccines for global health needs

Industry news / 29 October 2013 / GlaxoSmithKline

GSK and BMGF will invest a combined $1.8 million in early stage research into vaccine thermostability…

Abbott logo

Seven pharmaceutical companies join academic researchers to speed TB drug discovery

Industry news, News / 6 July 2012 / Abbott

Groundbreaking partnership that aims to speed the discovery of essential new treatments…

Novartis logo

Novartis increases growth potential through integration of Alcon

Industry news, News / 13 September 2011 / Novartis

Alcon to accelerate growth through Novartis strength in market access, reimbursement, and research capability…

Novartis logo

Novartis receives FDA approval for Arcapta(TM) Neohaler(TM)

Industry news, News / 1 July 2011 / Novartis

Novartis announced that the US FDA approved once-daily Arcapta(TM) Neohaler(TM) (indacaterol inhalation powder)…

Novartis logo

Novartis Phase III study shows once-daily NVA237 is superior to placebo

Industry news, News / 30 June 2011 / Novartis

Results from the pivotal Phase III GLOW2 clinical trial show that once-daily NVA237, 50 mcg significantly improved lung function…

Novartis logo

FDA panel endorses efficacy but not safety of Novartis drug ACZ885 for gouty arthritis

Industry news, News / 21 June 2011 / Novartis

FDA panel voted in favor of the overall efficacy but not the overall safety of ACZ885…

Novartis logo

FDA advisory committee recommends US approval of Novartis once-daily bronchodilator QAB149 for COPD

Industry news, News / 9 March 2011 / Novartis

An advisory committee recommended that the FDA approve QAB149 (indacaterol) in the US…

Novartis logo

Novartis studies show Onbrez® Breezhaler® & tiotropium provided greater increase in lung function than tiotropium alone

Industry news, News / 10 February 2011 / Novartis

Patients with COPD treated with Onbrez® Breezhaler® & tiotropium notice improvements…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...